Skip to main content

Research Repository

Advanced Search

Leukaemic and bone marrow stromal cells alter cytarabine genotoxicity and cytotoxicity in favour of disease

Gynn, Liana; Anderson, Elizabeth; Robinson, Gareth ; May, Jennifer

Authors

Liana Gynn

Gareth Robinson Gareth2.Robinson@uwe.ac.uk
Senior Lecturer in Molecular Microbiology

Jennifer May Jennifer2.May@uwe.ac.uk
Senior Lecturer in Biomedical Science



Abstract

Resistance to therapy remains one of the greatest challenges in the management of the blood and bone marrow (BM) disorder, acute myeloid leukaemia (AML). This study aimed to investigate how leukaemic and BM stromal cells contribute to altered chemo-sensitivity; with particular interest in genotoxicity protection of leukaemic cells and sensitisation of the supportive BM.
AML cells (HL-60 and K562) were mono-cultured or cocultured with a stromal (HS-5) cell line using trans-well inserts, prior to treatment with a physiological dose of cytarabine (25 µM); standard AML induction therapy. Toxicity protection and sensitisation were determined by genotoxicity (micronucleus/alkaline comet) assays, viability (dye exclusion), chemo-sensitivity (bacterial bioluminescent biosensor) and proliferation (CFSE fluorescence).
Leukaemic-stromal co-culture altered both cell types in favour of disease progression. HS-5 significantly reduced micronuclei formation (4.72/3.45%; p

Journal Article Type Meeting Abstract
Publication Date Dec 19, 2019
Print ISSN 0267-8357
Publisher Oxford University Press (OUP)
Peer Reviewed Peer Reviewed
Volume 34
Issue 5/6
Pages e5
APA6 Citation May, J., Gynn, L., Anderson, E., & Robinson, G. (2019). Leukaemic and bone marrow stromal cells alter cytarabine genotoxicity and cytotoxicity in favour of disease. Mutagenesis, 34(5/6), e5. https://doi.org/10.1093/mutage/gez025
DOI https://doi.org/10.1093/mutage/gez025
;